The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression.
European journal of cancer (Oxford, England : 1990)
View this publicationEuropean journal of cancer (Oxford, England : 1990)
View this publicationHemaSphere
View this publicationCancers
View this publicationFrontiers in digital health
View this publicationScientific reports
View this publicationTransplantation and cellular therapy
View this publicationRheumatology international
View this publicationCase reports in hematology
View this publicationRheumatology international
View this publicationTrends in cancer
View this publication